September 1, 2016
Pushing the boundaries of regenerative medicineBiopharmadealmakers Nature (2016)
Read full postMarch 1, 2016
COMMENTARY: Go parallel in a big wayDr Diana Hernandez. Drug Discovery News (2016) Vol. 12, Issue 3
Read full postJuly 1, 2015
Massively Parallel Combinatorial ScreeningDr Diana Hernandez. Genetic Engineering & Biotechnology News (2015) Vol. 35, No. 13
Read full postNovember 9, 2014
A Miracle Cure? We’re working on itMatthew Goodman. The Sunday Times (2014)
Read full postDecember 5, 2011
Stem Cell DifferentiationDr Lilian Hook. Drug Discovery World (Winter 2011)
Read full postDecember 1, 2011
Protocols Promote Stem Cell ProgressDr Lilian Hook. Drug Discovery & Development (2011)
Read full postNovember 15, 2010
Cell Culture Media ScreenGenetic Engineering & Biotechnology News (2010)
Read full postOctober 12, 2010
Plasticell launches second generation CombiCultTM screening platform Company wins Frost & Sullivan 2010 European Technology Innovation AwardLondon, UK, 12 October 2010 Plasticell, the biotechnology company specialising in high throughput screening for stem cell differentiation, announces the launch of its second generation CombicultTM 10,000-Plex Screen capable of rapidly screening up to ten thousand cell culture media combinations.
Read full postAugust 2, 2009
Combinatorial Cell Culture™ patent granted in Europe and other regionsLondon, UK, 2 August 2009. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has announced that patents protecting its proprietary cell culture technology, Combinatorial Cell Culture™ (CombiCult™), have been granted by the European Patent Office, Australian Patent Office and Intellectual Property Office of Singapore.
Read full postNovember 23, 2007
Plasticell closes first institutional financing roundLondon, UK, 23 November 2007. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has announced the closing of a ?690,000 financing round involving an institutional investor for the first time.
Read full post